Persistent trophoblast disease following partial molar pregnancy

The Australian & New Zealand Journal of Obstetrics & Gynaecology
Sabien WielsmaMichael Quinn

Abstract

Human chorionic gonadotrophin (hCG) follow-up data were analysed retrospectively in all patients registered in the Hydatidiform Mole Registry at the Royal Women's Hospital, Melbourne from January 1992 to January 2001 to determine the risk of persistent trophoblast disease following partial molar pregnancy and to review the present follow-up protocol of patients suffering from partial hydatidiform molar pregnancy (PHM). Demographic factors were determined for all 344 cases with a review diagnosis of PHM, included age, history of previous hydatidiform mole, gestation length, hCG levels and compliance with follow-up. Six of the 344 patients diagnosed with PHM required treatment with single-agent methotrexate and folinic acid rescue. All six patients achieved and maintained a complete biochemical remission after chemotherapy. hCG regression assays were analysed for 235 patients: 225 patients had at least one normal hCG measurement during follow-up, of whom 152 (64.7%) patients obtained normal values within 2 months after evacuation. All patients obtained normal levels within 32 weeks after evacuation of the partial hydatidiform mole. Only 63 (25.6%) patients completed the recommended follow-up program. No patient who achieved norma...Continue Reading

References

Jan 31, 1976·Lancet·P Vassilakos, T Kajii
Mar 6, 1976·Lancet·M Stone, K D Bagshawe
Sep 15, 1979·Lancet·S D LawlerA E Szulman
Jan 15, 1977·American Journal of Obstetrics and Gynecology·P VassilakosT Kajii
Jun 15, 1977·American Journal of Obstetrics and Gynecology·C P MorrowR M Nakamura
Jul 15, 1978·American Journal of Obstetrics and Gynecology·A E Szulman, U Surti
Mar 1, 1990·Gynecologic Oncology·L W RiceM R Bernstein
Sep 20, 1986·Lancet·K D BagshaweJ Webb
Feb 1, 1985·The Australian & New Zealand Journal of Obstetrics & Gynaecology·G OlesnickyB L Kneale
Mar 1, 1970·The Journal of Obstetrics and Gynaecology of the British Commonwealth·N A BeischerR Pepperell
Mar 1, 1983·American Journal of Obstetrics and Gynecology·J R LurainB Halpern
Jul 1, 1993·Journal of Clinical Pathology·A J HowatR A Williams
Jul 13, 2000·Lancet·M J SecklE S Newlands
Oct 21, 2000·International Journal of Gynaecology and Obstetrics : the Official Organ of the International Federation of Gynaecology and Obstetrics·J L BenedetS Pecorelli
Apr 4, 2001·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·E I Kohorn
Apr 10, 2003·Obstetrics and Gynecology·Colleen M FeltmateRoss S Berkowitz
Dec 23, 2003·European Journal of Obstetrics, Gynecology, and Reproductive Biology·Jozsef BatorfiVilmos Fulop
Jun 3, 2004·Obstetrics and Gynecology·UNKNOWN Committee on Practice Bulletins-Gynecology, American College of Obstetricians and Gynecologists
Sep 2, 2004·Obstetrics and Gynecology·Adam J WolfbergEllice Lieberman
May 20, 2005·American Journal of Obstetrics and Gynecology·Isaac LavieJohn O Schorge

❮ Previous
Next ❯

Citations

Apr 17, 2009·The New England Journal of Medicine·Ross S Berkowitz, Donald P Goldstein
Jun 23, 2009·The American Journal of Surgical Pathology·Thomas G McConnellKathleen M Murphy
May 14, 2014·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Michael J WorleyDonald P Goldstein
Jul 28, 2013·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Natalie BanetBrigitte M Ronnett
Jul 27, 2007·Journal of Obstetrics and Gynaecology : the Journal of the Institute of Obstetrics and Gynaecology·L F A WongN Gleeson
Apr 4, 2012·Cancer Genetics·Lori Hoffner, Urvashi Surti
Jun 21, 2011·Gynecologic Oncology·Mo'iad AlazzamJohn Tidy
Aug 3, 2010·Lancet·Michael J SecklRoss S Berkowitz
Apr 24, 2010·The Journal of Molecular Diagnostics : JMD·Alexis Norris-KirbyKathleen M Murphy
Jan 31, 2017·Annual Review of Pathology·Pei HuiBrigitte M Ronnett
Sep 2, 2011·The American Journal of Surgical Pathology·Cheryl DeScipioBrigitte M Ronnett
Feb 26, 2016·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Antonio BragaRoss Berkowitz
Apr 28, 2006·The Australian & New Zealand Journal of Obstetrics & Gynaecology·Linda KerkmeijerMichael Quinn
Dec 1, 2018·Archives of Pathology & Laboratory Medicine·Brigitte M Ronnett
Apr 7, 2019·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Natalia BuzaPei Hui
Mar 29, 2014·BJOG : an International Journal of Obstetrics and Gynaecology·M GueyeJ C Moreau
Oct 8, 2020·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Deyin XingBrigitte M Ronnett
Sep 28, 2020·Clinica Chimica Acta; International Journal of Clinical Chemistry·Bettina Chale-MatsauTahir S Pillay

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

American Journal of Obstetrics and Gynecology
Isaac LavieJohn O Schorge
European Journal of Obstetrics, Gynecology, and Reproductive Biology
Jozsef BatorfiVilmos Fulop
The Australian & New Zealand Journal of Obstetrics & Gynaecology
Linda G W KerkmeijerMichael Quinn
© 2022 Meta ULC. All rights reserved